Revolutionizing Care, One Beat at a Time

Through a complete reimagining of extracorporeal life support, we are transforming the landscape of critical care medicine. Our therapy provides optimal safety, easy operation, and unprecedented mobility for full heart-lung support.

Technology

Our therapy focuses on safety of the patient above all else. With a completely redesigned bio-inspired pump and maximally efficient oxygenator, our ECMO system offers advanced heart-lung support with a significant improvement in biocompatibility and a reduction in thrombocyte activation.

  • The oxygenator has been redesigned to maximize washout, reducing coagulation risk, and optimize gas exchange efficiency.

  • The bio-inspired positive displacement pump produces lower shear stress, reducing coagulation risk. Additionally, the pulsatile nature of the pumping mechanism reduces stagnant flow areas, further reducing coagulation risk.

  • Both pump and gas transfer are operated completely by gas pressure. This allows for a highly mobile and compact system for cardiopulmonary support wherever it is needed.

Applications

  • Clinical Settings

    High biocompatibility, small size, and optimized performance make the MOBYBOX ideal for traditional ECMO settings.

  • Ambulatory & Mobile use

    The compact and light weight design allow for high mobility. The simple operation facilitates ambulatory ECMO scenarios, allowing patients to mobilize and move around.

  • Emergency Scenarios

    The battery-less operation, unrivaled mobility, and simplicity in implementation and operation allow this ECMO to be used in forward and emergency scenarios. Bringing ECMO to the patient at the time of need.

Team

  • Nick Williams, PhD

    Co-Founder | Principal

    Over a decade of experience leading Research & Development teams to success. Nick received his PhD in Electrical and Computer Engineering from Duke and performed a Post-Doctoral fellowship at Northwestern in Materials Science.

  • Brian Chang, MD, PhD

    Co-Founder

    3rd time founder with extensive experience managing medical device development. Brian completed his MD at HMS and PhD in medical engineering at MIT.

InFlo Medical products are not cleared by the U.S. Food and Drug Administration and not available for human use or sale